Frost & Sullivan’s recent analysis of the global digital pathology market finds that it’s estimated to hit $825.9 million by 2025. Increasing pathology test volumes due to disease prevalence, digital pathology’s importance to the pharmaceutical industry, and regulatory approvals for using digital pathology in the primary diagnosis will boost the market.

Read More